GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genvec Inc (FRA:GVC2) » Definitions » Equity Investments

Genvec (FRA:GVC2) Equity Investments


View and export this data going back to . Start your Free Trial

What is Genvec Equity Investments?

Equity Investments only applies to insurance companies.


Genvec (FRA:GVC2) Business Description

Traded in Other Exchanges
N/A
Address
Genvec Inc was incorporated under the laws of the state of Delaware on December 7, 1992.The Company is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. Its development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus or RSV, herpes simplex virus or HSV, and malaria. In the area of animal health the Company is developing vaccines against foot-and-mouth disease or FMD. In collaboration with Novartis, the Companys hearing and balance disorders program is focused on the restoration of hearing and balance function through the regeneration of critical cells of the inner ear. The Company is currently developing preventative vaccines, against RSV and malaria and therapeutic vaccine against HSV.